Ventria Bioscience Inc. Scores Key Victory in Fight Against Infringing Chinese Recombinant Albumin

For immediate release – Junction City, KS  Last week, Ventria Bioscience Inc. obtained an important win in its effort to stop the importation and sale of infringing recombinant albumin made in China by Wuhan Healthgen Biotechnology Corp. On August 18, 2021, the U.S. International Trade Commission (ITC) formally found three U.S. distributors of such products—Aspira […]

0 comments
Antibodies attacking coronavirus covid-19

Secretory IgA: potential new weapon against respiratory transmission of SARS-CoV-2?

  The ongoing COVID-19 pandemic has become a major source of disruption and upheaval to normal daily routines. The repeated opening and re-shuttering of schools and universities in response to spiking case numbers, for example, highlights the need for preventative treatments before a return to normalcy is possible. While vaccines are being developed, other prevention […]

0 comments

Could IgA from Human Breast Milk Offer Insights into Potential Treatments for COVID-19?

As of the date of this writing, there have been more than 8 million confirmed cases of COVID-19 worldwide, and close to half a million deaths. The pandemic’s initial, exponential growth trajectory has been contained through massive voluntary and mandatory isolation efforts; however, these have had their own disastrous consequences for the economy and for […]

0 comments

Ventria Bioscience’s ExpressTec Delivers the Power to Improve the Health Status of Children in Developing Countries

Junction City, Kansas – November 21, 2019 – A recent publication, Human Milk Proteins: Their Power to Improve the Health Status of Children in Developing Countries, explores the critical health benefits of synthetic human breastmilk proteins for children in developing countries. In poverty-stricken areas, children are more likely to suffer from Environmental Enteric Dysfunction (EED) […]

0 comments

Human Milk Proteins: Their Power to Improve the Health Status of Children in Developing Countries

It has long been known that human breastmilk provides crucial health advantages to newborn infants as they develop, and has been a topic of intense research. Current clinical innovations seek to harness the benefits of human breastmilk to address global medical needs. With functions such as energy provision, immunologic power, and gut maturation, there are […]

0 comments

Design and Objectives of the ELCIE Clinical Trial

Effects of rhLactoferrin on Chronic Inflammation in the Elderly: Design and Objectives of the ELCIE Clinical Trial We have previously introduced an ongoing clinical study, headed by principal investigator Jeremy Walston, MD,  Johns Hopkins School of Medicine, aimed at finding out if recombinant human lactoferrin (rhLactoferrin) produced from Ventria Bioscience’s ExpressTec biologic manufacturing system may […]

0 comments

Breastmilk and the developing infant brain

In a previous post, we discussed how the composition of human breastmilk protects infant health and aids in the early development of the gut and immune system. We also talked about how some of those beneficial properties can be isolated to specific milk proteins that can now be produced affordably, in high yield, for clinical […]

0 comments

Studying a potential new insulin analog for diabetes therapy

Toward a better insulin analog: improving product yield enables scientific study of potential new diabetes therapy. Daily injections of the pancreatic peptide-hormone insulin are essential to life for many people living with type 1 or advanced type 2 diabetes. While therapeutic insulin was originally available only by purifying it from animal sources, in 1982 a […]

0 comments

Clinical study: can a protein derived from breastmilk palliate symptoms of inflammation in the elderly?

Through the process of natural selection, the components of mammalian breastmilk have been shaped over the course of millions of years. For each species of mammal, breastmilk provides not only the nutrients that neonates and infants require for proper growth and development outside of the womb, but also a host of components that protect the […]

0 comments

Ventria Bioscience partners with BMGF to address pediatric diarrhea in the developing world

In our last post, we discussed results from a re-analysis of the Global Enteric Multicenter Study (GEMS), which found that the key pathogens responsible for nearly 80% of worldwide cases of pediatric diarrhea are Shigella spp, rotavirus, adenovirus 40/41, heat-stable enterotoxigenic E. coli (ETEC), Cryptosporidium spp, and Campylobacter spp. Previously, we also discussed a study, […]

0 comments